Causes and Treatments for Various Phenotypes Among Autistic Individuals
DOI:
https://doi.org/10.58445/rars.1557Keywords:
Autism, Genetic, Non-Genetic, Causes, Treatments, Challenges, PhenotypesAbstract
This paper surveys genetic and non-genetic causes and emerging treatments for individuals with autism with challenges including stress, social, functional, emotional, and behavioral difficulties. Genetic treatments consist of methods to replace and edit DNA, along with reducing translation of mRNA that may have mutations, which would encode defective proteins. A key challenge with genetic treatments is finding a dosage amount that is not toxic to patients. Non-genetic treatments consist mainly of behavioral therapies and medications. Although these treatments can help to improve communication and decrease stress for some individuals, the medications may have some side effects, and improved behavior from behavioral therapies is not guaranteed, which would not always make these treatments excellent options. This paper also includes concerns about treatments including treatment delivery, ethical concerns about a certain behavioral therapy, treatment progressions in the long-term, treatments for coexisting conditions, and access and affordability of treatments. This paper concludes with an ethical discussion about genetic treatments using an Islamic framework.
References
Benger, M., Kinali, M., & Mazarakis, N. D. (2018). Autism spectrum disorder: Prospects for
treatment using gene therapy. In Molecular Autism (Vol. 9, Issue 1, pp. 4–6). BioMed
Central Ltd. https://doi.org/10.1186/s13229-018-0222-8
Beopoulos, A., Géa, M., Fasano, A., & Iris, F. (2023). RNA epitranscriptomics dysregulation: A
major determinant for significantly increased risk of ASD pathogenesis. Frontiers in
Neuroscience, 17, 11–11. https://doi.org/10.3389/fnins.2023.1101422
Beversdorf, D. Q., Ferguson, B., Hunter, S., Hirst, K., Lolli, B., Bellesheim, K. R., Barton, A. U.,
Muckerman, J., Takahashi, N., Selders, K., Holem, R., Sohl, K., Dyke, P., Stichter, J.,
Mazurek, M., & Kanne, S. (2024). Randomized controlled trial of propranolol on social
communication and anxiety in children and young adults with autism spectrum disorder.
Psychopharmacology, 241(1), 19–32. https://doi.org/10.1007/s00213-023-06452-1
Carr, D. R., & Bradshaw, S. E. (2016). Gene therapies: The challenge of super-high-cost
treatments and how to pay for them. Regenerative Medicine, 11(4), 381–393.
https://doi.org/10.2217/rme-2016-0010
Chang, Q., Yang, H., Wang, M., Wei, H., & Hu, F. (2018). Role of microtubule-associated
protein in autism spectrum disorder. In Neuroscience Bulletin (Vol. 34, Issue 6, pp.
–1126). Springer. https://doi.org/10.1007/s12264-018-0246-2
Eckes, T., Buhlmann, U., Holling, H. D., & Möllmann, A. (2023). Comprehensive ABA-based
interventions in the treatment of children with autism spectrum disorder – a meta
analysis. BMC Psychiatry, 23(1), 3–3. https://doi.org/10.1186/s12888-022-04412-1
Feder, J. (2023). Irritiability ASD 4.22.24. CARLAT, 1–1.
Fieiras, C., Chen, M. H., Escobar Liquitay, C. M., Meza, N., Rojas, V., Franco, J. V. A., &
Madrid, E. (2023). Risperidone and aripiprazole for autism spectrum disorder in children:
an overview of systematic reviews. BMJ evidence-based medicine, 28(1), 7–14.
https://doi.org/10.1136/bmjebm-2021-111804
Fischer, I., Shohat, S., Levy, G., Bar, E., Trangle, S. S., Efrati, S., & Barak, B. (2022).
Hyperbaric Oxygen Therapy Alleviates Social Behavior Dysfunction and
Neuroinflammation in a Mouse Model for Autism Spectrum Disorders. International
Journal of Molecular Sciences, 23(19), 4–7. https://doi.org/10.3390/ijms231911077
Garrison, L. P. J., Jiao, B., & Dabbous, O. (2021). Gene therapy may not be as expensive as
people think: challenges in assessing the value of single and short-term therapies.
Ghaly, M. (2019). GENOME EDITING BIOETHICAL CONCERNS Ghaly-Islamic-Ethical
Perspectives-SP19-ISSUES-45-48 3.17.24. Issues in Science and Technology, 3–4.
Genovese, A., & Butler, M. G. (2020). Clinical assessment, genetics, and treatment approaches
in autism spectrum disorder (ASD). In International Journal of Molecular Sciences (Vol.
, Issue 13, pp. 1–18). MDPI AG. https://doi.org/10.3390/ijms21134726
Genovese, A., & Butler, M. G. (2023). The Autism Spectrum: Behavioral, Psychiatric and
Genetic Associations. In Genes (Vol. 14, Issue 3, pp. 1–21). MDPI.
https://doi.org/10.3390/genes14030677
Harper, J. (2024). Psychology in the real world (2nd ed.). Soomo Learning.
Huang, M., Qi, Q., & Xu, T. (2023). Targeting Shank3 deficiency and paresthesia in autism
spectrum disorder: A brief review. In Frontiers in Molecular Neuroscience (Vol. 16, pp.
–3). Frontiers Media S.A. https://doi.org/10.3389/fnmol.2023.1128974
Kelly, E., Schaeffer, S. M., Dhamne, S. C., Lipton, J. O., Lindemann, L., Honer, M., Jaeschke,
G., Super, C. E., Lammers, S. H., Modi, M. E., Silverman, J. L., Dreier, J. R.,
Kwiatkowski, D. J., Rotenberg, A., & Sahin, M. (2018). MGluR5 modulation of behavioral
and epileptic phenotypes in a mouse model of tuberous sclerosis complex.
Neuropsychopharmacology, 43(6), 1457–1465. https://doi.org/10.1038/npp.2017.295
Leaf, J. B., Cihon, J. H., Leaf, R., McEachin, J., Liu, N., Russell, N., Unumb, L., Shapiro, S., &
Khosrowshahi, D. (2022). Concerns About ABA-Based Intervention: An Evaluation and
Recommendations. In Journal of Autism and Developmental Disorders (pp. 2838–2853).
Springer. https://doi.org/10.1007/s10803-021-05137-y
Makris, G., Agorastos, A., Chrousos, G. P., & Pervanidou, P. (2022). Stress System Activation
in Children and Adolescents With Autism Spectrum Disorder. In Frontiers in
Neuroscience (Vol. 15, pp. 3–6). Frontiers Media S.A.
https://doi.org/10.3389/fnins.2021.756628
Meyza, K. Z., & Blanchard, D. C. (2017). The BTBR mouse model of idiopathic autism – Current
view on mechanisms. In Neuroscience and Biobehavioral Reviews (Vol. 76, pp. 13–13).
Elsevier Ltd. https://doi.org/10.1016/j.neubiorev.2016.12.037
Qin, L., Wang, H., Ning, W., Cui, M., & Wang, Q. (2024). New advances in the diagnosis and
treatment of autism spectrum disorders. In European journal of medical research (Vol.
, Issue 1, pp. 1–2). https://doi.org/10.1186/s40001-024-01916-2
Wang, X., Zhao, J., Huang, S., Chen, S., Zhou, T., Li, Q., Luo, X., & Hao, Y. (2021). Cognitive
Behavioral Therapy for Autism Spectrum Disorders: A Systematic Review. In Behavioral
Therapy for Autism Spectrum Disorders: A Systematic Review. Pediatrics (Vol. 147,
Issue 5). http://publications.aap.org/pediatrics/article
pdf/147/5/e2020049880/1182167/peds_2020049880.pdf
Wiśniowiecka-Kowalnik, B., & Nowakowska, B. A. (2019). Genetics and epigenetics of autism
spectrum disorder—current evidence in the field. In Journal of Applied Genetics (Vol. 60,
Issue 1, pp. 37–47). Springer Verlag. https://doi.org/10.1007/s13353-018-00480-w
Downloads
Posted
Categories
License
Copyright (c) 2024 Abdullah Ali, Caren Papendorp
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.